Literature DB >> 30114001

Contraceptive Use Among Women at Risk for Unintended Pregnancy in the Context of Public Health Emergencies - United States, 2016.

Karen Pazol, Sascha R Ellington, Anna C Fulton, Lauren B Zapata, Sheree L Boulet, Marion E Rice, Shanna Cox, Lisa Romero, Eva Lathrop, Stacey Hurst, Charlan D Kroelinger, Howard Goldberg, Carrie K Shapiro-Mendoza, Regina M Simeone, Lee Warner, Dana M Meaney-Delman, Wanda D Barfield.   

Abstract

Ensuring access to and promoting use of effective contraception have been identified as important strategies for preventing unintended pregnancy (1). The importance of ensuring resources to prevent unintended pregnancy in the context of public health emergencies was highlighted during the 2016 Zika virus outbreak when Zika virus infection during pregnancy was identified as a cause of serious birth defects (2). Accordingly, CDC outlined strategies for state, local, and territorial jurisdictions to consider implementing to ensure access to contraception (3). To update previously published contraceptive use estimates* among women at risk for unintended pregnancy† and to estimate the number of women with ongoing or potential need for contraceptive services,§,¶ data on contraceptive use were collected during September-December 2016 through the Behavioral Risk Factor Surveillance System (BRFSS). Results from 21 jurisdictions indicated that most women aged 18-49 years were at risk for unintended pregnancy (range across jurisdictions = 57.4%-76.8%). Estimates of the number of women with ongoing or potential need for contraceptive services ranged from 368 to 617 per 1,000 women aged 18-49 years. The percentage of women at risk for unintended pregnancy using a most or moderately effective contraceptive method** ranged from 26.1% to 65.7%. Jurisdictions can use this information to estimate the number of women who might seek contraceptive services and to plan and evaluate efforts to increase contraceptive use. This information is particularly important in the context of public health emergencies, such as the recent Zika virus outbreak, which have been associated with increased risk for adverse maternal-infant outcomes (2,4-6) and have highlighted the importance of providing women and their partners with resources to prevent unintended pregnancy.

Entities:  

Mesh:

Year:  2018        PMID: 30114001      PMCID: PMC6095651          DOI: 10.15585/mmwr.mm6732a6

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


BRFSS is a cross-sectional jurisdiction-specific, random-digit–dialed, telephone survey that collects data on risk behaviors and preventive health practices among adult respondents living in the 50 states, the District of Columbia, Puerto Rico, Guam, and U.S. Virgin Islands. This report includes data from 21 jurisdictions that implemented the optional family planning module on self-reported contraceptive use during September–December 2016. Individual contraceptive methods from this module were classified according to first-year typical use failure rates as most effective (≤1% failure), moderately effective (>1%–10% failure), or less effective (>10% failure).*** Women reporting more than one contraceptive method were classified according to the most effective method they reported using. Weighted estimates and 95% confidence intervals were calculated to determine the proportion of women aged 18–49 years at risk for unintended pregnancy (defined as those who reported they were sexually active with a male partner, but did not report that they were currently pregnant or seeking pregnancy, that they would not mind being pregnant, or that they had a hysterectomy). In addition, numbers and rates (total number and number per 1,000 women aged 18–49 years) and corresponding 95% confidence intervals were calculated for women with ongoing or potential need for contraceptive services (defined as those at risk for unintended pregnancy who were not using permanent contraceptive methods [female sterilization or report of male partner vasectomy]). Estimates also were calculated to describe the proportion of women at risk for unintended pregnancy using contraception by effectiveness category (most effective, including permanent methods and long-acting reversible contraception [LARC]; moderately effective; less effective; and no method). Estimates for using either a less effective method or no method were further stratified by age group (18–24, 25–34, 35–44, and 45–49 years). Women at risk for unintended pregnancy who did not specify the type of contraception they used or reported “other” methods (4.8%) were excluded from estimates of contraceptive use by method effectiveness and from estimates of the number of women with ongoing or potential need for contraceptive services. Estimates that did not meet reliability standards established for BRFSS were suppressed. Among the 21 jurisdictions, the proportion of women aged 18–49 years at risk for unintended pregnancy ranged from 57.4% (Texas) to 76.8% (Minnesota) (Table 1). Jurisdictions with the fewest numbers of women with ongoing or potential need for contraceptive services included Guam, Kansas, Puerto Rico, and West Virginia; jurisdictions with the highest numbers included California, Florida, Illinois, and Texas. Estimates of the number of women with ongoing or potential need for contraceptive services per 1,000 women aged 18–49 years ranged from 368 in Puerto Rico to 617 in Maryland. Among women at risk for unintended pregnancy, the proportion using either a most or moderately effective contraceptive method ranged from 26.1% (Guam) to 65.7% (West Virginia) (Table 2); among 11 jurisdictions with reliable estimates for LARC, use ranged from 5.5% (Kansas) to 17.0% (Maryland). Among 18 jurisdictions with reliable estimates, the percentage of women at risk for unintended pregnancy using a less effective method of contraception ranged from 11.1% (Illinois) to 47.7% (Arizona), and among 19 jurisdictions, the percentage not using any method of contraception ranged from 16.5% (Virginia) to 63.0% (Guam) (Table 3). Across age-stratified estimates, the percentage using either a less effective method or no method ranged from 25.9% (women aged 35–44 years in South Carolina) to 79.9% (women aged 18–24 years in California) (Supplementary Table, https://stacks.cdc.gov/view/cdc/57915).
TABLE 1

Percentage of women aged 18–49 years at risk for unintended pregnancy* and numbers of women with ongoing or potential need for contraceptive services,, by jurisdiction — Behavioral Risk Factor Surveillance System, 21 jurisdictions, September–December, 2016

JurisdictionTotal no. of women aged 18–49 years% of women aged 18–49 years at risk for unintended pregnancy (95% CI)Women with ongoing or potential need for contraceptive services
No. (95% CI)No. per 1,000 aged 18–49 years (95% CI)
Alabama
1,022,400
64.6 (56.9–71.6)
418,200 (342,500–498,400)
409 (335–487)
Arizona
1,400,300
57.9 (42.9–71.5)
683,400 (487,400–882,200)
488 (348–630)
California
8,585,800
67.6 (60.3–74.1)
4,464,500 (3,817,200–5,104,000)
520 (445–594)
Connecticut
737,700
67.2 (51.5–79.9)
378,800 (283,900–472,400)
514 (385–640)
Florida
4,027,500
59.9 (53.4–66.1)
1,803,900 (1,566,300–2,047,500)
448 (389–508)
Georgia
2,252,800
62.5 (50.3–73.2)
1,089,400 (828,400–1,354,400)
484 (368–601)
Illinois
2,745,600
74.1 (63.9–82.1)
1,675,800 (1,380,200–1,944,600)
610 (503–708)
Kansas
588,900
71.9 (66.8–76.5)
297,100 (262,900–331,300)
505 (446–563)
Kentucky
913,400
71.8 (66.8–76.3)
447,900 (397,400–498,600)
490 (435–546)
Louisiana
997,700
62.1 (44.0–77.3)
387,800 (227,600–576,400)
389 (228–578)
Maryland
1,299,200
75.8 (69.3–81.3)
801,200 (707,500–888,600)
617 (545–684)
Minnesota
1,126,900
76.8 (70.3–82.3)
596,800 (502,200–689,700)
530 (446–612)
New Jersey
1,862,500
76.6 (65.4–85.0)
1,142,400 (922,100–1,340,300)
613 (495–720)
Ohio
2,359,500
61.5 (52.9–69.4)
1,105,200 (907,800–1,306,900)
468 (385–554)
Oklahoma
805,100
65.8 (58.5–72.5)
376,800 (318,000–436,600)
468 (395–542)
South Carolina
1,021,100
70.3 (62.7–76.9)
548,300 (461,100–633,400)
537 (452–620)
Texas
6,011,100
57.4 (47.4–66.9)
2,435,800 (1,888,700–3,025,200)
405 (314–503)
Virginia
1,813,800
71.6 (64.1–78.1)
938,500 (799,900–1,075,600)
517 (441–593)
West Virginia
360,400
67.6 (61.4–73.3)
158,200 (136,700–180,300)
439 (379–500)
Guam
35,200
70.3 (59.2–79.4)
20,800 (16,500–24,700)
591 (469–702)
Puerto Rico795,70063.7 (58.8–68.4)292,900 (255,600–332,200)368 (321–417)

Abbreviation: CI = confidence interval.

* Women were considered at risk for unintended pregnancy unless they reported that they were not sexually active with a male partner, that they were currently pregnant or seeking pregnancy, that they would not mind being pregnant, or that they had a hysterectomy.

† Women with ongoing or potential need for contraceptive services were defined as those women considered at risk for unintended pregnancy who were not using permanent contraceptive methods (female sterilization or report of male partner vasectomy).

§The number of women with ongoing or potential need for contraceptive services can be used to predict how many women might seek services; this measure does not represent unmet need for contraception because many of these women might already be using some method of contraception: https://www.guttmacher.org/sites/default/files/report_pdf/contraceptive-needs-and-services-2014_1.pdf.

¶ Numbers are rounded to the nearest 100.

TABLE 2

Percentage of women aged 18–49 years at risk for unintended pregnancy* using most or moderately effective contraceptive methods, by jurisdiction — Behavioral Risk Factor Surveillance System, 21 jurisdictions, September–December, 2016

JurisdictionTotal
Most effective
Moderately effective
Most or moderately effective
Sterilization
Long-acting reversible (LARC)
% (95% CI)% (95% CI)% (95% CI)% (95% CI)
Alabama
63.8 (54.0–72.5)
35.7 (26.6–46.0)

19.1 (12.5–28.2)
Arizona
39.1 (25.1–55.1)



California
51.5 (42.0–60.9)
22.5 (16.5–29.9)
11.7 (7.5–17.8)
17.2 (12.4–23.4)
Connecticut
55.4 (44.5–65.9)
21.9 (15.0–31.0)
9.4 (5.5–15.7)
24.1 (14.6–37.0)
Florida
48.6 (42.0–55.2)
22.9 (17.3–29.6)
9.7 (6.5–14.4)
16.0 (12.0–21.0)
Georgia
51.5 (36.9–65.8)
22.3 (12.0–37.7)


Illinois
62.4 (50.5–73.0)
16.8 (10.0–26.7)

33.3 (21.0–48.3)
Kansas
60.9 (53.7–67.7)
28.9 (23.0–35.8)
5.5 (3.3–9.1)
26.4 (20.6–33.2)
Kentucky
60.1 (53.4–66.5)
31.3 (25.1–38.2)
6.6 (4.1–10.6)
22.2 (17.0–28.4)
Louisiana
56.9 (32.1–78.7)
35.0 (18.7–55.8)


Maryland
62.3 (53.8–70.1)
17.6 (12.7–23.9)
17.0 (11.0–25.4)
27.7 (19.5–37.6)
Minnesota
60.2 (50.2–69.4)
29.9 (21.3–40.2)
11.8 (6.6–20.2)
18.5 (11.1–29.2)
New Jersey
50.8 (37.2–64.2)
16.3 (10.5–24.5)


Ohio
45.4 (35.7–55.3)
22.9 (16.6–30.6)
7.6 (4.4–13.0)
14.8 (10.0–21.5)
Oklahoma
62.5 (53.0–71.1)
28.2 (21.3–36.3)

27.0 (19.5–36.0)
South Carolina
61.5 (50.3–71.7)
22.8 (15.5–32.3)
10.5 (5.8–18.3)
28.2 (19.4–39.2)
Texas
53.0 (40.7–65.1)
27.3 (17.7–39.5)

20.5 (12.8–31.1)
Virginia
60.8 (51.9–68.9)
26.8 (20.0–35.0)
13.3 (7.8–21.7)
20.7 (14.8–28.0)
West Virginia
65.7 (58.9–72.0)
34.4 (27.8–41.6)
11.0 (6.5–17.9)
20.4 (15.0–27.0)
Guam
26.1 (15.2–41.0)



Puerto Rico49.8 (43.6–55.9)41.6 (35.7–47.8)6.8 (4.1–11.1)

Abbreviation: CI = confidence interval

* Women were considered at risk for unintended pregnancy unless they reported that they were not sexually active with a male partner, that they were currently pregnant or seeking pregnancy, that they would not mind being pregnant, or that they had a hysterectomy.

† Most effective contraceptive methods included permanent methods (female sterilization or report of male partner vasectomy) and long-acting reversible contraception (LARC, including intrauterine devices [IUDs] and contraceptive implants); most effective methods have a ≤1% failure rate during the first year of typical use. Sources: Trussell J. Contraceptive failure in the United States. Contraception 2011;83:397–404. Sundaram A, Vaughan B, Kost K, et al. Contraceptive failure in the United States: estimates from the 2006–2010 National Survey of Family Growth. Perspect Sex Reprod Health 2017;49:7–16.

§ Moderately effective contraceptive methods included contraceptive injectables, contraceptive pills, transdermal contraceptive patches, and vaginal rings; moderately effective methods have a >1%–10% failure rate with typical use. Sources: Trussell J. Contraceptive failure in the United States. Contraception 2011;83:397–404. Sundaram A, Vaughan B, Kost K, et al. Contraceptive failure in the United States: estimates from the 2006–2010 National Survey of Family Growth. Perspect Sex Reprod Health 2017;49:7–16.

¶ Estimate is unreliable (relative standard error >30% or denominator <50).

TABLE 3

Percentage of women aged 18–49 years at risk for unintended pregnancy* using less effective contraceptive methods or no method, by jurisdiction — Behavioral Risk Factor Surveillance System, 21 jurisdictions, September–December, 2016

JurisdictionTotal
Less effective method
No method
Less effective or no method
% (95% CI)% (95% CI)% (95% CI)
Alabama
36.2 (27.5–46.0)
13.6 (8.3–21.6)
22.6 (15.6–31.6)
Arizona
60.9 (44.9–74.9)
47.7 (31.0–65.0)
§
California
48.5 (39.1–58.0)
31.6 (21.9–43.2)
16.9 (12.3–22.9)
Connecticut
44.6 (34.1–55.5)
20.4 (13.0–30.6)
24.1 (16.4–34.1)
Florida
51.4 (44.8–58.0)
14.1 (10.2–19.3)
37.3 (31.2–43.9)
Georgia
48.5 (34.2–63.1)

34.1 (21.9–48.8)
Illinois
37.6 (27.0–49.5)
11.1 (6.2–19.1)
26.4 (18.0–37.0)
Kansas
39.1 (32.3–46.3)
14.5 (10.4–19.8)
24.6 (18.7–31.7)
Kentucky
39.9 (33.5–46.6)
20.0 (15.0–26.1)
19.9 (15.5–25.2)
Louisiana
43.1 (21.3–67.9)


Maryland
37.7 (29.9–46.2)
18.8 (13.3–26.0)
18.9 (13.4–25.8)
Minnesota
39.8 (30.6–49.8)
13.1 (8.1–20.6)
26.7 (19.0–36.1)
New Jersey
49.2 (35.8–62.8)
18.3 (10.7–29.6)
30.9 (21.3–42.5)
Ohio
54.6 (44.7–64.3)
22.2 (13.0–35.2)
32.5 (23.5–43.0)
Oklahoma
37.5 (28.9–47.0)
11.8 (7.9–17.3)
25.7 (17.8–35.6)
South Carolina
38.5 (28.3–49.7)
11.3 (7.7–16.3)
27.2 (17.6–39.5)
Texas
47.0 (34.9–59.3)
16.0 (9.8–24.9)
31.0 (19.7–45.0)
Virginia
39.2 (31.1–48.1)
22.7 (15.6–31.8)
16.5 (11.9–22.4)
West Virginia
34.3 (28.0–41.1)
11.9 (8.4–16.7)
22.3 (17.2–28.5)
Guam
74.0 (59.0–84.8)

63.0 (47.7–76.0)
Puerto Rico50.2 (44.1–56.4)20.1 (15.5–25.6)30.2 (24.8–36.1)

Abbreviation: CI = confidence interval.

* Women were considered at risk for unintended pregnancy unless they reported that they were not sexually active with a male partner, that they were currently pregnant or seeking pregnancy, that they would not mind being pregnant, or that they had a hysterectomy.

† Less effective contraceptive methods included diaphragms, condoms (male or female), withdrawal, cervical caps, sponges, spermicides, fertility-awareness based methods, and emergency contraception; less effective methods have a >10% failure rate during the first year of typical use. Sources: Trussell J. Contraceptive failure in the United States. Contraception 2011;83:397–404. Sundaram A, Vaughan B, Kost K, et al. Contraceptive failure in the United States: estimates from the 2006–2010 National Survey of Family Growth. Perspect Sex Reprod Health 2017;49:7–16.

§ Estimate is unreliable (relative standard error >30% or denominator <50).

Abbreviation: CI = confidence interval. * Women were considered at risk for unintended pregnancy unless they reported that they were not sexually active with a male partner, that they were currently pregnant or seeking pregnancy, that they would not mind being pregnant, or that they had a hysterectomy. Women with ongoing or potential need for contraceptive services were defined as those women considered at risk for unintended pregnancy who were not using permanent contraceptive methods (female sterilization or report of male partner vasectomy). §The number of women with ongoing or potential need for contraceptive services can be used to predict how many women might seek services; this measure does not represent unmet need for contraception because many of these women might already be using some method of contraception: https://www.guttmacher.org/sites/default/files/report_pdf/contraceptive-needs-and-services-2014_1.pdf. ¶ Numbers are rounded to the nearest 100. Abbreviation: CI = confidence interval * Women were considered at risk for unintended pregnancy unless they reported that they were not sexually active with a male partner, that they were currently pregnant or seeking pregnancy, that they would not mind being pregnant, or that they had a hysterectomy. † Most effective contraceptive methods included permanent methods (female sterilization or report of male partner vasectomy) and long-acting reversible contraception (LARC, including intrauterine devices [IUDs] and contraceptive implants); most effective methods have a ≤1% failure rate during the first year of typical use. Sources: Trussell J. Contraceptive failure in the United States. Contraception 2011;83:397–404. Sundaram A, Vaughan B, Kost K, et al. Contraceptive failure in the United States: estimates from the 2006–2010 National Survey of Family Growth. Perspect Sex Reprod Health 2017;49:7–16. § Moderately effective contraceptive methods included contraceptive injectables, contraceptive pills, transdermal contraceptive patches, and vaginal rings; moderately effective methods have a >1%–10% failure rate with typical use. Sources: Trussell J. Contraceptive failure in the United States. Contraception 2011;83:397–404. Sundaram A, Vaughan B, Kost K, et al. Contraceptive failure in the United States: estimates from the 2006–2010 National Survey of Family Growth. Perspect Sex Reprod Health 2017;49:7–16. ¶ Estimate is unreliable (relative standard error >30% or denominator <50). Abbreviation: CI = confidence interval. * Women were considered at risk for unintended pregnancy unless they reported that they were not sexually active with a male partner, that they were currently pregnant or seeking pregnancy, that they would not mind being pregnant, or that they had a hysterectomy. † Less effective contraceptive methods included diaphragms, condoms (male or female), withdrawal, cervical caps, sponges, spermicides, fertility-awareness based methods, and emergency contraception; less effective methods have a >10% failure rate during the first year of typical use. Sources: Trussell J. Contraceptive failure in the United States. Contraception 2011;83:397–404. Sundaram A, Vaughan B, Kost K, et al. Contraceptive failure in the United States: estimates from the 2006–2010 National Survey of Family Growth. Perspect Sex Reprod Health 2017;49:7–16. § Estimate is unreliable (relative standard error >30% or denominator <50).

Discussion

Across the 21 jurisdictions, the number of women with ongoing or potential need for contraceptive services per 1,000 women aged 18–49 years ranged from 368 to 617 and exceeded 4 million in total in the jurisdiction with the highest number of women with ongoing or potential need for contraceptive services. The proportion of women at risk for unintended pregnancy using a most or moderately effective method of contraception ranged from 26.1% to 65.7%. The proportion using no contraception ranged from 16.5% to 63.0%. These data can be used for jurisdictional planning and are particularly important in the context of public health emergencies associated with increased risk for adverse maternal-infant outcomes that heighten the need to provide women and their partners with resources to prevent unintended pregnancy. The data for this report were collected because of concerns about Zika virus–related adverse pregnancy and birth outcomes; however, the findings have broader implications. Several types of public health emergencies, such as natural disasters, including hurricanes, have been associated with adverse maternal-infant outcomes, along with disruptions in women’s abilities to access contraception and interruptions in method use (,). Similarly, given the ongoing opioid crisis and high proportion of unintended pregnancies among women who misuse opioids (), ensuring access to contraception and preconception care among these women is an important strategy for reducing the incidence of neonatal abstinence syndrome (). Moreover, ensuring access to effective contraception is important in general for supporting women and their partners in planning their pregnancies and is also cost-saving (), particularly during public health emergencies such as the Zika virus outbreak where costs associated with long-term care of children with adverse birth outcomes are high (). Jurisdiction-level data are important because of the substantial variation among jurisdictions in unintended pregnancy rates (). Although a number of sociodemographic factors contribute to this variation, implementation of programs and policies that increase access to contraception, including the most effective methods, also varies considerably among jurisdictions. During the Zika virus outbreak response, CDC worked with jurisdictional partners to implement strategies to promote increased access to contraception (). Frequently adopted strategies included maintaining sustainable partnerships among insurers, manufacturers, and state agencies; reimbursing for the full range of contraceptive services; maintaining continuous stocking and supply of devices in a wide range of service facilities; and training providers on current insertion and removal techniques for the most effective methods. Although developed during the Zika virus response, these strategies apply broadly to all situations in which women and their partners need access to resources to prevent unintended pregnancy. This report provides data both for estimating the number of women who might seek services and for evaluating the impact of policies and programs. Understanding how many women need contraceptive services and where the need is greatest can aid in planning health care delivery.**** In addition, the proportion of women at risk for unintended pregnancy using a most or moderately effective contraceptive method is an established indicator of quality family planning service provision and a Healthy People 2020 objective. This indicator is critical for evaluating the success of implementation strategies and population-level impact (). Conversely, variation in prevalence of use of less effective contraceptive methods or no method, as documented in this report by age group, can be used to identify the need for targeted implementation of strategies, such as provision of youth-friendly services (). The findings in this report are subject to at least five limitations. First, information on contraceptive use was self-reported and might be subject to recall or social desirability bias. Second, because data for this report were collected over a 4-month period versus an entire year, small sample sizes limited the precision of estimates. Third, it was not possible to determine whether those reporting unspecified methods were using permanent or reversible methods. Estimates of the number of women with ongoing or potential need for contraceptive services therefore excluded these women and might have underestimated the number who might seek services; conversely, these estimates included women using LARC, who might only need services every 3–10 years depending on the type of LARC (). Fourth, this report includes data from only 21 jurisdictions and is not representative of other jurisdictions; however, it highlights the need for ongoing collection of jurisdiction-level data for all U.S. jurisdictions. Finally, nonresponse bias remains a possibility, although the weighting methodology used by BRFSS adjusts for nonresponse bias. Ensuring access to effective contraception is an important strategy for preventing unintended pregnancy and can be particularly important in the context of certain public health responses. During the Zika virus outbreak, contraception served as a medical countermeasure to prevent Zika virus-affected pregnancies and is similarly important in other contexts where risk for adverse maternal-infant outcomes is increased. The data in this report can be applied in nonemergency settings to help jurisdictions estimate the number of women who might seek contraceptive services and to plan and evaluate implementation strategies.

What is already known about this topic?

Ensuring access to contraception is an effective strategy for preventing unintended pregnancy and associated negative maternal-infant outcomes.

What is added by this report?

Data from 21 jurisdictions collected during a 4-month period indicated the number of women with ongoing or potential need for contraceptive services per 1,000 women aged 18–49 years. ranged from 368 to 617. The proportion at risk for unintended pregnancy using a most or moderately effective contraceptive method ranged from 57.4% to 76.8%. The proportion using no contraception ranged from 16.5% to 63.0%.

What are the implications for public health practice?

The recent Zika virus outbreak highlighted the need for contraception data in the context of public health responses associated with adverse maternal-infant outcomes. These data can inform delivery of contraceptive services and evaluation of implementation strategies to increase access to contraception.
  10 in total

1.  Contraceptive availability during an emergency response in the United States.

Authors:  Sascha R Ellington; Athena P Kourtis; Kathryn M Curtis; Naomi Tepper; Susan Gorman; Denise J Jamieson; Marianne Zotti; Wanda Barfield
Journal:  J Womens Health (Larchmt)       Date:  2013-02-19       Impact factor: 2.681

2.  Zika Virus and Birth Defects--Reviewing the Evidence for Causality.

Authors:  Sonja A Rasmussen; Denise J Jamieson; Margaret A Honein; Lyle R Petersen
Journal:  N Engl J Med       Date:  2016-04-13       Impact factor: 91.245

3.  Practice Bulletin No. 186: Long-Acting Reversible Contraception: Implants and Intrauterine Devices.

Authors: 
Journal:  Obstet Gynecol       Date:  2017-11       Impact factor: 7.661

4.  Unintended pregnancy rates at the state level.

Authors:  Lawrence B Finer; Kathryn Kost
Journal:  Perspect Sex Reprod Health       Date:  2011-05-19

5.  Importance of Performance Measurement and MCH Epidemiology Leadership to Quality Improvement Initiatives at the National, State and Local Levels.

Authors:  Kristin M Rankin; Loretta Gavin; John W Moran; Charlan D Kroelinger; Catherine J Vladutiu; David A Goodman; William M Sappenfield
Journal:  Matern Child Health J       Date:  2016-11

6.  Health concerns of women and infants in times of natural disasters: lessons learned from Hurricane Katrina.

Authors:  William M Callaghan; Sonja A Rasmussen; Denise J Jamieson; Stephanie J Ventura; Sherry L Farr; Paul D Sutton; Thomas J Mathews; Brady E Hamilton; Katherine R Shealy; Dabo Brantley; Sam F Posner
Journal:  Matern Child Health J       Date:  2007-01-26

7.  Return on investment: a fuller assessment of the benefits and cost savings of the US publicly funded family planning program.

Authors:  Jennifer J Frost; Adam Sonfield; Mia R Zolna; Lawrence B Finer
Journal:  Milbank Q       Date:  2014-10-15       Impact factor: 4.911

8.  Cost-effectiveness of Increasing Access to Contraception during the Zika Virus Outbreak, Puerto Rico, 2016.

Authors:  Rui Li; Katharine B Simmons; Jeanne Bertolli; Brenda Rivera-Garcia; Shanna Cox; Lisa Romero; Lisa M Koonin; Miguel Valencia-Prado; Nabal Bracero; Denise J Jamieson; Wanda Barfield; Cynthia A Moore; Cara T Mai; Lauren C Korhonen; Meghan T Frey; Janice Perez-Padilla; Ricardo Torres-Muñoz; Scott D Grosse
Journal:  Emerg Infect Dis       Date:  2017-01-15       Impact factor: 6.883

9.  CDC Grand Rounds: Public Health Strategies to Prevent Neonatal Abstinence Syndrome.

Authors:  Jean Y Ko; Sara Wolicki; Wanda D Barfield; Stephen W Patrick; Cheryl S Broussard; Kimberly A Yonkers; Rebecca Naimon; John Iskander
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-03-10       Impact factor: 17.586

10.  Meeting Summary: State and Local Implementation Strategies for Increasing Access to Contraception During Zika Preparedness and Response - United States, September 2016.

Authors:  Charlan D Kroelinger; Lisa Romero; Eva Lathrop; Shanna Cox; Isabel Morgan; Meghan T Frey; Lee Warner; Kathryn M Curtis; Karen Pazol; Wanda D Barfield; Dana Meaney-Delman; Denise J Jamieson
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-11-10       Impact factor: 17.586

  10 in total
  5 in total

1.  Racial/ethnic variations in alcohol and cigarette use by pregnancy status among 20- to 44-year-old women, NHANES 2001-2018.

Authors:  Jacqueline M Hirth; Catherine Valadez; Sandra Gonzalez; Alicia Kowalchuk; Judith A Gutierrez; Roger Zoorob
Journal:  Womens Health (Lond)       Date:  2022 Jan-Dec

2.  Geospatiotemporal and causal inference study of cannabis and other drugs as risk factors for female breast cancer USA 2003-2017.

Authors:  Albert Stuart Reece; Gary Kenneth Hulse
Journal:  Environ Epigenet       Date:  2022-03-01

3.  Built environment, adiposity, and physical activity in adults aged 50-75.

Authors:  Fuzhong Li; Peter A Harmer; Bradley J Cardinal; Mark Bosworth; Alan Acock; Deborah Johnson-Shelton; Jane M Moore
Journal:  Am J Prev Med       Date:  2008-07       Impact factor: 5.043

4.  Need for Contraceptive Services Among Women of Reproductive Age - 45 Jurisdictions, United States, 2017-2019.

Authors:  Lauren B Zapata; Karen Pazol; Kathryn M Curtis; Debra J Kane; Tara C Jatlaoui; Suzanne G Folger; Ekwutosi M Okoroh; Shanna Cox; Maura K Whiteman
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-06-25       Impact factor: 17.586

5.  Healthcare system indicators associated with modern contraceptive use in Ghana, Kenya, and Nigeria: evidence from the Performance Monitoring and Accountability 2020 data.

Authors:  Ibitola Asaolu; Velia Leybas Nuño; Kacey Ernst; Douglas Taren; John Ehiri
Journal:  Reprod Health       Date:  2019-10-26       Impact factor: 3.223

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.